sialoglycolipids

01/01/1990 - "[The membrane sialoglycolipids of tumor cells and the metastasis of bone tumors]."
12/01/1992 - "Sialoglycolipids shed by tumor cells have been implicated in tumor-induced inhibition of T-lymphocyte responses to interleukin-2 (IL-2). "
11/01/1980 - "The findings suggest that astrocytoma tumors shed sialoglycolipids into the circulation, and their assay may be useful in monitoring oncological therapy."
01/01/2018 - "Cell-surface sialoglycoconjugates (sialoglycoproteins and sialoglycolipids) play important roles in cell-cell interactions and related tumor metastasis process. "
01/01/1990 - "Chondro- and osteogenic sarcoma revealed different profiles of sialoglycolipids, particularly, due to markedly reduced set of gangliosides and nearly complete loss of polysialogangliosides in the latter tumor."

01/01/1990 - "[The membrane sialoglycolipids of tumor cells and the metastasis of bone tumors]."
01/01/2018 - "Cell-surface sialoglycoconjugates (sialoglycoproteins and sialoglycolipids) play important roles in cell-cell interactions and related tumor metastasis process. "

01/13/1976 - "Changes in these membrane sialoglycolipids and sialoglycopeptides were not influenced by Rauscher leukemia virus infection. "
01/01/1986 - "The experiments carried out to test the ability of sialoglycolipids (gangliosides) and asialoglycolipids (cerebrosides) to inhibit virus attachment to CER cells or to goose erythrocytes showed that only gangliosides were able to inhibit VSV infection and haemagglutination."

03/29/1996 - "The metabolic processing of sialoglycolipids (gangliosides) was investigated in cultures of skin fibroblasts obtained from two patients affected with Salla disease. "

01/01/1990 - "Chondro- and osteogenic sarcoma revealed different profiles of sialoglycolipids, particularly, due to markedly reduced set of gangliosides and nearly complete loss of polysialogangliosides in the latter tumor."